Faculty of Science and Engineering (Applied Chemistry) Professor Teruyuki Komatsu’s research team has been successful in developing artificial blood for dogs.
Komatsu and his team have synthesized an oxygen-carrying protein, a cluster of a structure of hemoglobin enclosed in genetically modified dog serum albumin (hemoglobin-GM dog serum albumin) (brand name: HemoAct-C™), and clarified its function as an artificial oxygen-carrying substance for dogs (artificial red blood cells). This is a revolutionary invention that will provide an immediate solution for the severe issue of “securing blood for transfusions” that surrounds the veterinary medicine field, and is expected to make a huge contribution to animal blood transfusion therapy.
Teruyuki Komatsu (Chuo University Faculty of Science and Engineering, Applied Chemistry Department / Professor)
Motofusa Akiyama (Chuo University Faculty of Science and Engineering, Applied Chemistry Department / Assistant Professor)
Kana Yamada (Chuo University Graduate School of Science and Engineering / Master’s Program 2nd year)
Conference title：22nd Annual Meeting of the Society of Blood Substitutes, Japan.
Dates: October 22 (Thurs) – 23 (Fri), 2015
Venue: Miyamoto Memorial Hall, Faculty of Pharmaceutical Sciences, Kumamoto University
Presentation date: October 22, 2015 (Thurs)
Session: Symposium 2
Research toward the Practical Application of the Artificial Oxygen-Carrying Substance “HemoAct”
Development of Artificial Blood for Dogs
For more information, please visit the press release (pdf file) and link below.
Press Release: Development of artificial blood for dogs (October 19, 2015 Chuo University)(PDF:436KB）
Bioinorganic Chemistry/ Komatsu Laboratory